207 related articles for article (PubMed ID: 36701845)
1. Case Report of Erdheim-Chester Disease Successfully Treated with Pegylated Interferon: A Single-Center Experience.
Lim Y; Yoon SE; Cho J; Kim D; Jung CW
Cancer Res Treat; 2023 Jul; 55(3):1053-1057. PubMed ID: 36701845
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults.
Cao XX; Sun J; Li J; Zhong DR; Niu N; Duan MH; Liang ZY; Zhou DB
Ann Hematol; 2016 Apr; 95(5):745-50. PubMed ID: 26858028
[TBL] [Abstract][Full Text] [Related]
3. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
[TBL] [Abstract][Full Text] [Related]
4. Erdheim-Chester disease.
Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
Curr Rheumatol Rep; 2014 Apr; 16(4):412. PubMed ID: 24532298
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
[TBL] [Abstract][Full Text] [Related]
6. [Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia].
Haroche J; Papo M; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Presse Med; 2017 Jan; 46(1):96-106. PubMed ID: 27234902
[TBL] [Abstract][Full Text] [Related]
7. Hypoalphalipoproteinemia and BRAF
Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009
[TBL] [Abstract][Full Text] [Related]
8. Erdheim-Chester disease in a child.
Wen C; Liang Q; Yi Z; Wan W
West Indian Med J; 2012 Nov; 61(8):834-7. PubMed ID: 23757907
[TBL] [Abstract][Full Text] [Related]
9. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis.
Hao X; Feng R; Bi Y; Liu Y; Li C; Lu T; Tian Y
J Neurosurg Pediatr; 2018 Sep; 23(1):48-53. PubMed ID: 30265230
[TBL] [Abstract][Full Text] [Related]
10. Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease.
Cao XX; Niu N; Sun J; Cai H; Wang FD; Wang YN; Duan MH; Zhou DB; Li J
Orphanet J Rare Dis; 2019 Jan; 14(1):11. PubMed ID: 30630516
[TBL] [Abstract][Full Text] [Related]
11. A case of Erdheim-Chester disease with spinal cord compression and sphenoid sinus involvement.
Bunaux K; Sevestre H; Emile JF; Capel C; Chenin L; Peltier J
Neurochirurgie; 2018 Dec; 64(6):439-441. PubMed ID: 30274919
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy and interferon-alpha treatment of Erdheim-Chester disease.
Jeon IS; Lee SS; Lee MK
Pediatr Blood Cancer; 2010 Oct; 55(4):745-7. PubMed ID: 20589628
[TBL] [Abstract][Full Text] [Related]
13. Does the BRAF(V600E) mutation herald a new treatment era for Erdheim-Chester disease? A case-based review of a rare and difficult to diagnose disorder.
Bosco J; Allende A; Varikatt W; Lee R; Stewart GJ
Intern Med J; 2015 Mar; 45(3):348-51. PubMed ID: 25735579
[TBL] [Abstract][Full Text] [Related]
14. The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease.
Dai JW; Lin H; Chang L; Li J; Zhou DB; Cao XX
Ann Hematol; 2023 Dec; 102(12):3335-3343. PubMed ID: 37922006
[TBL] [Abstract][Full Text] [Related]
15. Erdheim-Chester Disease: a comprehensive review of the literature.
Mazor RD; Manevich-Mazor M; Shoenfeld Y
Orphanet J Rare Dis; 2013 Sep; 8():137. PubMed ID: 24011030
[TBL] [Abstract][Full Text] [Related]
16. [Erdheim-Chester disease].
Haroche J; Cohen-Aubart F; Arnaud L; Hervier B; Charlotte F; Drier A; Gorochov G; Grenier PA; Cluzel P; Maksud P; Emile JF; Amoura Z
Rev Med Interne; 2014 Nov; 35(11):715-22. PubMed ID: 24878295
[TBL] [Abstract][Full Text] [Related]
17. Erdheim-chester disease revealed by diabetes insipidus.
Amor BB; Sayadi H; Jemel M; Mrabet H; Hadhri R; Slim T; Klii R; Khochtali I
Pan Afr Med J; 2019; 33():293. PubMed ID: 31692902
[TBL] [Abstract][Full Text] [Related]
18. Effective High-dose Interferon-α Therapy in a 13-Year-Old Girl With Erdheim-Chester Disease.
Tezol O; Citak EC; Ayhan YS; Balci Y; Koc ZP; Yuyucu Karabulut Y
J Pediatr Hematol Oncol; 2020 May; 42(4):326-331. PubMed ID: 31259822
[TBL] [Abstract][Full Text] [Related]
19. An effective treatment in Erdheim Chester disease: vemurafenib: a case report.
Bozan E; Darçın T; Yaman S; Yiğenoğlu TN; Kızıl Çakar M; Dal MS; Altuntaş F
J Med Case Rep; 2023 Oct; 17(1):426. PubMed ID: 37821987
[TBL] [Abstract][Full Text] [Related]
20. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.
Hervier B; Haroche J; Arnaud L; Charlotte F; Donadieu J; Néel A; Lifermann F; Villabona C; Graffin B; Hermine O; Rigolet A; Roubille C; Hachulla E; Carmoi T; Bézier M; Meignin V; Conrad M; Marie L; Kostrzewa E; Michot JM; Barete S; Taly V; Cury K; Emile JF; Amoura Z;
Blood; 2014 Aug; 124(7):1119-26. PubMed ID: 24894769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]